| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.65 | 0.0007 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |